Simplify the Creation, Release, and Management of Multilingual Content

Reduce your cycle times and translation costs while improving resource allocation and achieving greater visibility

Learn More

Drive Consistency and Transparency with GlobalLink TMS

TransPerfect’s translation management system (TMS) helps leading life sciences organizations:

Automate Manual Processes

Automate manual tasks

Magnifying Glass with a Clock

Ensure a comprehensive audit trail, including a clear record of who made changes and when they were made

Checklist 2

Facilitate a collaborative online review process to eliminate the need for an email with marked-up files

AI Integrations

Centrally manage and leverage translation memory (TM) and other linguistic assets

Data

Capture important data for reporting and KPI metrics

Network 2

Integrate with other content repositories

Centralize your content in a web-based, intuitive, and secure platform

Streamlining processes to reduce cycle times and increase efficiency is an increasing trend within the life sciences industry. TransPerfect’s enabling translation technology platform, GlobalLink, automates manual steps, drives consistency through central translation memories (TMs) and linguistic assets, incorporates machine translation (MT) workflows, and offers real-time reporting for greater visibility and control. GlobalLink TMS streamlines the translation process and provides standardization that can accelerate the time-to-market by 40–60% and decrease translation costs by 25–40%.

GlobalLink TMS at a Glance

6 k+

Clients trust GlobalLink

50 %

Reduction in translation costs

40 %

Reduction in cycle times

50 %

Reduction of internal project management and IT dependencies

50 +

Out-of-the-box connectors for automation

GxP and CFR 21 Part 11 compliant

Key partnerships, including Veeva and Adobe

Translation Management Technology That Supports Your Growth

Sponsors supporting global operations produce vast amounts of content in need of translation. The complexity of content volume, tight timelines, quality and compliance concerns, administrative burden, and budget constraints all challenge the efficiency of managing content translation at scale.

TransPerfect Life Sciences' TMS solutions help sponsors navigate content complexities by driving process automation, improving TM efficacy and consistency, incorporating MT workflows, and optimizing content review to shorten cycle times and reduce total translation costs.

Learn More ›

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

Learn Why Leading Life Sciences Organizations Love GlobalLink TMS

Schedule a Demo.

Name of Employee

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in clinical trial management.

XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI

Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring that therapeutics are safe, accurately labeled and compliantly communicated to healthcare professionals and patients. Yet in practice, the boundaries between these functions are rarely clean; a safety signal surfaced through an MI inquiry can trigger a PV investigation, which in turn may prompt a label update, a Risk Management ...

XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI

Webinar

LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts. ...

Blog

Regulatory Considerations for Paper COA Translations | What You Need to Know

Collecting data for a global clinical trial on paper COAs or managing a mixed-mode study that combines both paper and electronic formats means satisfying multiple regulatory bodies before a single patient enrolls. None of these entities operate on the same timeline or...

Blog

When "How Does the Patient Feel?" Became a Regulatory Question

For decades, clinical trials were built around things you could measure with a machine: tumor shrinkage on a scan, laboratory values, and disease progression. These hard, objective endpoints were the backbone of drug approval. The patient's own account of how they felt,...

Webinar

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects ...

Webinar

SSCPs Are Not Labeling: Compliant AI Processes for Reduced Cost & Turnaround

In this fireside chat, TransPerfect Medical Device's President Marc Miller sits down with Dr. Keith Morel, VP of Regulatory Compliance at Qserve, to unpack a critical question facing medical device manufacturers under MDR: can you reduce the translation review process for ...

Success Stories

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...